WOCKHARDT
Back to Income Statement
|
WOCKHARDT Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹-463 Cr | ₹-559 Cr | ₹-244 Cr | ₹686 Cr | ₹-69 Cr |
What is the latest Consolidated Net Profit of WOCKHARDT ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹-463 Cr |
Mar2023 | ₹-559 Cr |
Mar2022 | ₹-244 Cr |
Mar2021 | ₹686 Cr |
Mar2020 | ₹-69 Cr |
How is Consolidated Net Profit of WOCKHARDT Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹-463 Cr | Negative | |
Mar2023 | ₹-559 Cr | Negative | |
Mar2022 | ₹-244 Cr | Negative | |
Mar2021 | ₹686 Cr | Positive | |
Mar2020 | ₹-69 Cr | - |
Compare Consolidated Net Profit of peers of WOCKHARDT
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WOCKHARDT | ₹24,839.8 Cr | 4.4% | 22.1% | 180.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹403,868.0 Cr | 0.3% | -5.5% | 14.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹176,010.0 Cr | 0.3% | 7.9% | 53.5% | Stock Analytics | |
CIPLA | ₹120,318.0 Cr | 1.7% | -1.3% | 1.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,644.0 Cr | 3.1% | 11.2% | 8.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹106,406.0 Cr | -1% | -4.4% | 16.3% | Stock Analytics |
WOCKHARDT Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WOCKHARDT | 4.4% |
22.1% |
180.8% |
SENSEX | -0.2% |
1% |
10.2% |
You may also like the below Video Courses